Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDElevance Health Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 17 | $9.57 | $11.73 | $10.62 |
| Q2 2025 | 9 | $9.90 | $10.71 | $10.16 |
| Q3 2025 | 8 | $8.47 | $9.16 | $8.70 |
| Q4 2025 | 14 | $4.50 | $4.87 | $4.62 |
| Q1 2026 | 7 | $12.15 | $13.14 | $12.47 |
| Q2 2026 | 12 | $11.33 | $12.26 | $11.63 |
| Q3 2026 | 7 | $9.48 | $10.26 | $9.73 |
| Q4 2026 | 7 | $5.48 | $5.92 | $5.62 |
| Q1 2027 | 7 | $12.93 | $13.98 | $13.27 |
| Q2 2027 | 7 | $12.12 | $13.11 | $12.44 |
| Q3 2027 | 10 | $10.88 | $11.77 | $11.17 |
| Q4 2027 | 7 | $7.96 | $8.61 | $8.17 |
Elevance Health Inc. Earnings Date And Information
Elevance Health Inc. last posted its earnings results on Thursday, January 23rd, 2025. The company reported $3.84 earnings per share for the quarter, topping analysts' consensus estimates of $3.8 by $0.04. The company had revenue of 45.44 B for the quarter and had revenue of 176.81 B for the year. Elevance Health Inc. has generated $26 earnings per share over the last year ($25.68 diluted earnings per share) and currently has a price-to-earnings ratio of 15.64. Elevance Health Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 22nd, 2025 based on prior year's report dates.
Elevance Health Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/20/2025 | Q4 2024 | N/A | $1.84 | N/A | $44.95 B | $45.44 B |
| 10/17/2024 | Q3 2024 | $9.66 | $4.36 | -5.3 | $43.47 B | $45.15 B |
| 07/17/2024 | Q2 2024 | $10.01 | $9.91 | -0.1 | $42.99 B | $43.65 B |
| 04/18/2024 | Q1 2024 | $10.53 | $9.65 | -0.88 | N/A | $42.58 B |
| 02/21/2024 | Q4 2023 | N/A | $3.67 | N/A | $42.19 B | $42.65 B |
| 10/18/2023 | Q3 2023 | $8.45 | $5.48 | -2.97 | $42.76 B | $42.85 B |
| 07/19/2023 | Q2 2023 | $8.80 | $7.83 | -0.97 | $41.64 B | $43.67 B |
| 04/19/2023 | Q1 2023 | $9.26 | $8.37 | -0.89 | N/A | $42.17 B |
| 02/15/2023 | Q4 2022 | N/A | $3.99 | N/A | N/A | $39.93 B |
| 10/19/2022 | Q3 2022 | $7.15 | $6.75 | -0.4 | $39.29 B | $39.94 B |
| 07/20/2022 | Q2 2022 | $7.74 | $6.87 | -0.87 | $37.91 B | $38.63 B |
| 04/20/2022 | Q1 2022 | $7.81 | $7.48 | -0.33 | N/A | $38.10 B |
| 02/16/2022 | Q4 2021 | N/A | $4.70 | N/A | N/A | $36.58 B |
| 10/20/2021 | Q3 2021 | $6.37 | $6.20 | -0.17 | $35.35 B | $35.82 B |
| 07/21/2021 | Q2 2021 | $6.33 | $7.33 | 1 | $33.13 B | $33.85 B |
| 04/21/2021 | Q1 2021 | $6.51 | $6.80 | 0.29 | N/A | $32.39 B |
| 02/18/2021 | Q4 2020 | N/A | $2.23 | N/A | N/A | $31.82 B |
| 10/28/2020 | Q3 2020 | $4.15 | $0.88 | -3.27 | $29.86 B | $31.16 B |
| 07/29/2020 | Q2 2020 | $8.87 | $9.02 | 0.15 | $29.39 B | $29.26 B |
| 04/29/2020 | Q1 2020 | $6.48 | $6.03 | -0.45 | N/A | $29.62 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Elevance Health Inc. Earnings: FAQ's
Elevance Health Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 22nd, 2025 based offlast year's report dates.
In the previous quarter, Elevance Health Inc. (:ELV) reported $3.84 earnings per share (EPS) to beat the analysts' consensus estimate of $3.8 by $0.04.
The conference call for Elevance Health Inc.'s latest earnings report can be listened to online.
The conference call transcript for Elevance Health Inc.'s latest earnings report can be read online.
Elevance Health Inc. (:ELV) has a recorded annual revenue of $176.81 B.
Elevance Health Inc. (:ELV) has a recorded net income of $5.98 B.Elevance Health Inc. has generated $26.29 earnings per share over the last four quarters.
Elevance Health Inc. (:ELV) has a price-to-earnings ratio of 15.64 and price/earnings-to-growth ratio is -2.36.